First Trust Advisors LP Actinium Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.67 $295,332 - $495,809	-51,273 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.01 - $8.63 $108,879 - $134,041	15,532 Added 43.46%	51,273 $406,000
Q1 2021 May 14, 2021	BUY	$7.62 - $9.79 $21,861 - $28,087	2,869 Added 8.73%	35,741 $272,000
Q4 2020 Feb 02, 2021	SELL	$7.8 - $12.64 $11,551 - $18,719	-1,481 Reduced 4.31%	32,872 $256,000
Q3 2020 Nov 05, 2020	BUY	$7.26 - $18.0 $249,402 - $618,354	34,353 New	34,353 $333,000

8.32M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $35.5M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.